Odonate Therapeutics Chief Medical Officer Joseph O'Connell's 2020 pay falls 31% to $1.4M
Odonate Therapeutics reports 2020 executive compensation
By ExecPay News
Published: June 1, 2021
Odonate Therapeutics reported fiscal year 2020 executive compensation information on June 1, 2021.
In 2020, three executives at Odonate Therapeutics received on average a compensation package of $648K, a 45% decrease compared to previous year.
Average pay of disclosed executives at Odonate Therapeutics
Joseph P. O'Connell, Chief Medical Officer, received $1.4M in total, which decreased by 31% compared to 2019. 60% of O'Connell's compensation, or $829K, was in option awards. O'Connell also received $142K in non-equity incentive plan, $375K in salary, as well as $26K in other compensation.
Michael Hearne, Chief Financial Officer, received a compensation package of $572K. 56% of the compensation package, or $321K, was in option awards.
Kevin C. Tang, Chief Executive Officer, earned $1 in 2020, which is the same as previous year.
Related executives
You may also like
Source: SEC filing on June 1, 2021.